Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William M Watkins

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Clinical Pharmacology and Therapeutics|December 21, 2006
Sulfadoxine-pyrimethamine pharmacokinetics in malaria: pediatric dosing implicationsKaren I Barnes, Francesca Little, Peter J Smith, et al.
The Journal of Infectious Diseases|June 3, 2008
Characteristics of Plasmodium falciparum dhfr haplotypes that confer pyrimethamine resistance, Kilifi, Kenya, 1987--2006Laura K Certain, Marnie Briceño, Steven M Kiara, et al.
Experimental Eye Research|October 1, 2013
Hypoxia-induced expression of VEGF splice variants and protein in four retinal cell typesWilliam M Watkins, Gary W McCollum, Sara R Savage, et al.
Malaria Journal|December 28, 2010
Implementation of a reference standard and proficiency testing programme by the World Wide Antimalarial Resistance Network (WWARN)Chris Lourens, William M Watkins, Karen I Barnes, et al.
The American Journal of Tropical Medicine and Hygiene|July 15, 2005
Reduction of the efficacy of antifolate antimalarial therapy by folic acid supplementationJane Y Carter, Mores P Loolpapit, Orgenes E Lema, et al.
Experimental Parasitology|November 13, 2002
Plasmodium falciparum: in vitro activity of sulfadoxine and dapsone in field isolates from Kenya: point mutations in dihydropteroate synthase may not be the only determinants in sulfa resistanceEdward K Mberu, Alexis M Nzila, Eunice Nduati, et al.
British Journal of Clinical Pharmacology|July 10, 2003
Pharmacokinetics and clinical effects of phenytoin and fosphenytoin in children with severe malaria and status epilepticusBernhards R Ogutu, Charles R J C Newton, Simon N Muchohi, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2005
Antimalarial benzo[c]phenanthridinesJames M Nyangulu, Samantha L Hargreaves, Susan L Sharples, et al.
Malaria Journal|September 8, 2007
World Antimalarial Resistance Network (WARN) IV: clinical pharmacologyKaren I Barnes, Niklas Lindegardh, Olumide Ogundahunsi, et al.
The Journal of Infectious Diseases|October 23, 2004
Rare, highly pyrimethamine-resistant alleles of the Plasmodium falciparum dihydrofolate reductase gene from 5 African sitesSarah J Bates, Peter A Winstanley, William M Watkins, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Clinical Pharmacology and Therapeutics|December 21, 2006
Sulfadoxine-pyrimethamine pharmacokinetics in malaria: pediatric dosing implicationsKaren I Barnes, Francesca Little, Peter J Smith, et al.
The Journal of Infectious Diseases|June 3, 2008
Characteristics of Plasmodium falciparum dhfr haplotypes that confer pyrimethamine resistance, Kilifi, Kenya, 1987--2006Laura K Certain, Marnie Briceño, Steven M Kiara, et al.
Experimental Eye Research|October 1, 2013
Hypoxia-induced expression of VEGF splice variants and protein in four retinal cell typesWilliam M Watkins, Gary W McCollum, Sara R Savage, et al.
Malaria Journal|December 28, 2010
Implementation of a reference standard and proficiency testing programme by the World Wide Antimalarial Resistance Network (WWARN)Chris Lourens, William M Watkins, Karen I Barnes, et al.
The American Journal of Tropical Medicine and Hygiene|July 15, 2005
Reduction of the efficacy of antifolate antimalarial therapy by folic acid supplementationJane Y Carter, Mores P Loolpapit, Orgenes E Lema, et al.
Experimental Parasitology|November 13, 2002
Plasmodium falciparum: in vitro activity of sulfadoxine and dapsone in field isolates from Kenya: point mutations in dihydropteroate synthase may not be the only determinants in sulfa resistanceEdward K Mberu, Alexis M Nzila, Eunice Nduati, et al.
British Journal of Clinical Pharmacology|July 10, 2003
Pharmacokinetics and clinical effects of phenytoin and fosphenytoin in children with severe malaria and status epilepticusBernhards R Ogutu, Charles R J C Newton, Simon N Muchohi, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2005
Antimalarial benzo[c]phenanthridinesJames M Nyangulu, Samantha L Hargreaves, Susan L Sharples, et al.
Malaria Journal|September 8, 2007
World Antimalarial Resistance Network (WARN) IV: clinical pharmacologyKaren I Barnes, Niklas Lindegardh, Olumide Ogundahunsi, et al.
The Journal of Infectious Diseases|October 23, 2004
Rare, highly pyrimethamine-resistant alleles of the Plasmodium falciparum dihydrofolate reductase gene from 5 African sitesSarah J Bates, Peter A Winstanley, William M Watkins, et al.
Pageof 3